314 related articles for article (PubMed ID: 11735631)
1. Underutilisation of ACE inhibitors in patients with congestive heart failure.
Bungard TJ; McAlister FA; Johnson JA; Tsuyuki RT
Drugs; 2001; 61(14):2021-33. PubMed ID: 11735631
[TBL] [Abstract][Full Text] [Related]
2. Patterns of physician use of angiotensin converting enzyme inhibitors in the inpatient treatment of congestive heart failure.
Ghali JK; Giles T; Gonzales M; Horswell R; Kumar S; Lejuene A; Livaudais GF; Sarkar IC
J La State Med Soc; 1997 Dec; 149(12):474-84. PubMed ID: 9425858
[TBL] [Abstract][Full Text] [Related]
3. Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals.
Philbin EF; Andreaou C; Rocco TA; Lynch LJ; Baker SL
Am J Cardiol; 1996 Apr; 77(10):832-8. PubMed ID: 8623735
[TBL] [Abstract][Full Text] [Related]
4. Community pharmacist outreach program directed at physicians treating congestive heart failure.
Turner CJ; Parfrey P; Ryan K; Miller R; Brown A
Am J Health Syst Pharm; 2000 Apr; 57(8):747-52. PubMed ID: 10786260
[TBL] [Abstract][Full Text] [Related]
5. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure: an observational study of treatment rates and clinical outcome.
Gotsman I; Rubonivich S; Azaz-Livshits T
Isr Med Assoc J; 2008 Mar; 10(3):214-8. PubMed ID: 18494235
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin converting enzyme (ACE) inhibitors and heart failure. The consequences of underprescribing.
Andersson F; Cline C; Rydén-Bergsten T; Erhardt L
Pharmacoeconomics; 1999 Jun; 15(6):535-50. PubMed ID: 10538327
[TBL] [Abstract][Full Text] [Related]
7. Factors determining angiotensin-converting enzyme inhibitor underutilization in heart failure in a community setting.
Philbin EF
Clin Cardiol; 1998 Feb; 21(2):103-8. PubMed ID: 9491949
[TBL] [Abstract][Full Text] [Related]
8. Beta-blockers and angiotensin-converting enzyme inhibitors/receptor blockers prescriptions after hospital discharge for heart failure are associated with decreased mortality in Alberta, Canada.
Johnson D; Jin Y; Quan H; Cujec B
J Am Coll Cardiol; 2003 Oct; 42(8):1438-45. PubMed ID: 14563589
[TBL] [Abstract][Full Text] [Related]
9. Differences in generalist and specialist physicians' knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure.
Chin MH; Friedmann PD; Cassel CK; Lang RM
J Gen Intern Med; 1997 Sep; 12(9):523-30. PubMed ID: 9294785
[TBL] [Abstract][Full Text] [Related]
10. Pharmacoeconomic considerations in assessing and selecting congestive heart failure therapies.
Levy E; Levy P
Pharmacoeconomics; 2002; 20(14):963-77. PubMed ID: 12403637
[TBL] [Abstract][Full Text] [Related]
11. What is the role of angiotensin-converting enzyme inhibitors in congestive heart failure and after myocardial infarction?
Nelson KM; Yeager BF
Ann Pharmacother; 1996 Sep; 30(9):986-93. PubMed ID: 8876861
[TBL] [Abstract][Full Text] [Related]
12. Determinants of mortality in elderly patients with heart failure: the role of angiotensin-converting enzyme inhibitors.
Havranek EP; Abrams F; Stevens E; Parker K
Arch Intern Med; 1998 Oct; 158(18):2024-8. PubMed ID: 9778202
[TBL] [Abstract][Full Text] [Related]
13. Temporal patterns in the medical treatment of congestive heart failure with angiotensin-converting enzyme inhibitors in older adults, 1989 through 1995.
Smith NL; Psaty BM; Pitt B; Garg R; Gottdiener JS; Heckbert SR
Arch Intern Med; 1998 May; 158(10):1074-80. PubMed ID: 9605778
[TBL] [Abstract][Full Text] [Related]
14. Patterns of pharmacologic treatment of congestive heart failure in elderly nursing home residents and related issues: a review of the literature.
Litaker JR; Chou JY
Clin Ther; 2003 Jul; 25(7):1918-35. PubMed ID: 12946542
[TBL] [Abstract][Full Text] [Related]
15. Determinants of angiotensin-converting enzyme inhibitor prescription in severe heart failure with left ventricular systolic dysfunction: the EPICAL study.
Echemann M; Zannad F; Briançon S; Juillière Y; Mertès PM; Virion JM; Villemot JP
Am Heart J; 2000 Apr; 139(4):624-31. PubMed ID: 10740143
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme inhibitors prescription is associated with longer survival among patients hospitalized for congestive heart failure who have preserved systolic function: a long-term follow-up study.
Grigorian Shamagian L; Roman AV; Ramos PM; Veloso PR; Bandin Dieguez MA; Gonzalez-Juanatey JR
J Card Fail; 2006 Mar; 12(2):128-33. PubMed ID: 16520261
[TBL] [Abstract][Full Text] [Related]
17. Physician, organisational and patient characteristics explaining the use of angiotensin converting enzyme inhibitors in heart failure treatment: a multilevel study.
Kasje WN; Denig P; Stewart RE; de Graeff PA; Haaijer-Ruskamp FM
Eur J Clin Pharmacol; 2005 Apr; 61(2):145-51. PubMed ID: 15761751
[TBL] [Abstract][Full Text] [Related]
18. Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology.
Gambassi G; Lapane KL; Sgadari A; Carbonin P; Gatsonis C; Lipsitz LA; Mor V; Bernabei R
Arch Intern Med; 2000 Jan; 160(1):53-60. PubMed ID: 10632305
[TBL] [Abstract][Full Text] [Related]
19. Quality of congestive heart failure treatment at a Canadian teaching hospital.
Weil E; Tu JV
CMAJ; 2001 Aug; 165(3):284-7. PubMed ID: 11517643
[TBL] [Abstract][Full Text] [Related]
20. Trends in prescribing ACE-inhibitors for congestive heart failure in elderly people.
Antonelli Incalzi R; Pedone C; Pahor M; Onder G; Carbonin PU;
Aging Clin Exp Res; 2002 Dec; 14(6):516-21. PubMed ID: 12674493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
